A great review in @NatRevDrugDisc on innate immunity targeting #Immunotherapy https://t.co/ia7OMPWScK pic.twitter.com/e6PAmPV0B3
— soria (@jsoriamd) April 12, 2019
There's so much about #AI's black box algorithms. But what about the unknown mechanism of action for ketamine, a derivative of which was just @US_FDA approved for #depression. Now there's some light on that:https://t.co/wvE3A6qUUY by @anna_beyeler pic.twitter.com/CCHfltyQgL
— Eric Topol (@EricTopol) April 11, 2019
“Authors identify a molecular mechanism that activates the transcription of genes related to an inactivated gene, thereby compensating for the knockout.” □ https://t.co/0thdlGLx8L
— Dr. Zoidberg (@psuvafan007) April 5, 2019
A call to retire statistical significance: when > 800 scientists say enough is enough, "The tool has become the tyrant"https://t.co/FIKB3V5h6d
— Eric Topol (@EricTopol) March 20, 2019
by @vamrhein @Lester_Domes and a long list
with this week's @Nature editorial https://t.co/H4IUcAwmCM pic.twitter.com/RlarATcTao
Very proud of this special issue @CellCellPress #editorial, outlining our vision of human #genetics / #genomics research. Where are we now, where are we headed and what do we have to surmount to get there? Would love your thoughts! https://t.co/LVB9LcnKi9 @cellpressnews pic.twitter.com/BZJVL87yC1
— Stacie Dodgson (@sed9) March 21, 2019
Gorgeous story from @NavitorPharma on the discovery of a drug that mimics a natural and specific activating signal for mTORC1 with a biodistribution that enables interesting therapeutic applications, particularly in CNS. Congrats @GVlasuk @ShomitSengupta https://t.co/mrVj8dxBDh
— Vipin Suri (@VipinSuri4) March 11, 2019
terrific collection of papers this week - Focus On Cancer Therapy @NatureMedicinehttps://t.co/1GjcrJlEah#glioblastoma #melanoma #immunotherapy #oncology #pediatric_cancer #microbiome #epigenetics
— Paul D. Rennert (@PDRennert) March 9, 2019
NO link with autism. Period. #VaccinesSaveLives https://t.co/WdYrfq7TWQ
— Raphaël Rousseau (@RaphaelRousseau) March 6, 2019
From the March issue - turning cold tumours hot https://t.co/NmweGXB9Ct Galon and Bruni discuss how understanding the mechanisms responsible for hot, altered or cold immune tumours could be harnessed to improve cancer #immunotherapy pic.twitter.com/Tol4ckFYWA
— Nature Rev Drug Disc (@NatRevDrugDisc) March 4, 2019
RSS Feed
